Blueprint
Blueprint is a private healthcare M&A and real estate advisory firm (operating as Blueprint Healthcare Real Estate Advisors) that facilitates sales of behavioral healthcare businesses and associated real estate, serving healthcare founders seeking exits and private equity-backed buyers entering new markets.
- Company typePrivate
- Founded2005
- HeadquartersManchester, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Blueprint does
Per the available firmographic record, Blueprint (also referred to as Blueprint Partnership) is a private, for-profit company founded in 2005, headquartered in Manchester, United Kingdom, with 11–50 employees. The firmographic profile characterizes it as a pharmaceutical research agency, though the broader data corpus describes activities consistent with healthcare M&A and real estate advisory under the name 'Blueprint Healthcare Real Estate Advisors.'
The more substantive source data documents the firm as a healthcare-focused M&A and real estate advisory that facilitates the sale of behavioral healthcare businesses and their associated real estate. Its core service is managing complex, combined business-and-real-estate transactions for healthcare entrepreneurs seeking exits, as evidenced by the Parkdale Center engagement in Northwest Indiana, which included partial hospitalization, intensive outpatient, and counseling operations. The firm also serves institutional buyers (e.g., a private equity-backed inpatient and outpatient provider) entering new geographic markets, and has managed competitive sale processes with multiple offers.
The business model is transaction-based advisory, with revenue tied to individual deal closures rather than recurring fees or subscription revenue. Pricing is not publicly disclosed. The firm operates in the United States market based on documented transactions, though its principal office is listed in Manchester, UK — a geographic inconsistency that suggests either cross-border advisory operations or a data-aggregation artifact between two distinct entities sharing the 'Blueprint' name. No technology platform, product suite, or proprietary tooling is documented in the source material.
Blueprint firmographics
Firmographics- Name
- Blueprint
- Website
- https://blueprintpartnership.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Blueprint is a private healthcare M&A and real estate advisory firm (operating as Blueprint Healthcare Real Estate Advisors) that facilitates sales of behavioral healthcare businesses and associated real estate, serving healthcare founders seeking exits and private equity-backed buyers entering new markets.
- Ownership category
- akta.pro rank
Blueprint industry classification
Industry- Product category
- Pharmaceutical Research Services
- NAICS
- Professional, Scientific, and Technical Services (541)
- akta.pro primary industry
- Value Dossier & Evidence Generation (AMCP/Global Value Dossier) (HLAIAKAC)
- akta.pro secondary industry
- Medical Writing & Publications (Clinical/Safety/HEOR) (HLAGALAG)
Keywords
Where Blueprint is headquartered
LocationHeadquarters
- HQ city
- Manchester
- HQ country
- United Kingdom
- HQ region
- Europe
Markets served
Blueprint business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales
Blueprint product offering
Product offeringCore offering
Firmographic data identifies Blueprint as a pharmaceutical research agency headquartered in Manchester, UK with 11-50 employees and founded in 2005. Documented business activity includes healthcare M&A advisory services through Blueprint Healthcare Real Estate Advisors, facilitating the sale of behavioral healthcare businesses and associated real estate in the US market, including transactions involving both operating businesses and real estate assets.
Product overview
No product information available in the provided source data. The source material describes Blueprint Healthcare Real Estate Advisors as a healthcare real estate advisory firm that facilitates the sale of behavioral healthcare businesses, not a technology product company.
Differentiator
Problem solved
Functional benefit
Products and services
- Healthcare M&A and Real Estate Advisory Facilitates the sale of behavioral healthcare businesses and associated real estate assets. Manages competitive sale processes with multiple offers and handles complex transactions involving both operating businesses and real estate. Serves healthcare entrepreneurs seeking exits and PE/strategic buyers seeking market entry.
Companies that use Blueprint
Customer profileNamed customers2 records
Segments1 record
Ideal customer profiles2 records
Blueprint technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Blueprint partnerships and signals
Strategic signalScale indicators2 records
Recent moves3 records
Expansion highlights3 records
Blueprint competitors and assessment
Company assessmentBroad incumbents
- Kantar Health: A large global healthcare market research and analytics provider operating as part of Kantar. Comparable in pharma research services but operates at much greater scale and with broader syndicated data products.
- IQVIA: The world's largest life sciences data, technology, and services platform offering market research alongside RWE, clinical, and commercial services. A key scale competitor for pharma research engagements.
- ZS Associates: A global consulting firm with a substantial pharmaceutical research and insights practice spanning market access, commercial strategy, and real-world evidence. Comparable in serving pharma commercial teams but at consulting scale.
- ICON plc: A global CRO and clinical research services firm with an established commercial and market access research practice. Comparable in pharma market access research but embedded in a much broader clinical services portfolio.
Emerging players
- Inizio Advisory: A newly assembled pharma commercialization advisory platform formed via UDG/Inizio, aggregating market access, medical affairs, and insights capabilities. A growing consolidator and potential competitive threat to independent boutiques.
Direct peers
- Research in Real Life (RiRL): A pharma market access research firm focused on payer, HTA, and real-world evidence insights. Comparable in market access research positioning and client base.
- The Research Partnership: A London-based boutique pharmaceutical market research agency offering qualitative and quantitative research across therapy areas. Closely comparable to Blueprint in scale, UK base, and dedicated pharma research focus.
- Adelphi Group (Adelphi Research): A UK-headquartered pharmaceutical market research and business intelligence firm with deep therapy-area expertise. Highly comparable as a boutique pharma research specialist in the UK market.
- SKIM: A specialized market research agency with strong pharma and healthcare practices across pricing, market access, and stakeholder insights. Comparable in boutique positioning and methodology emphasis.
- Cello Health: A healthcare-focused research and advisory firm serving pharma clients with insights, evidence, and communications services. Directly comparable in vertical focus and pharma client base.
Market position
Weaknesses4 records
Competitive moat3 records
Key risks4 records
Key highlights4 records
Customer concentration
Blueprint social profiles
Digital presenceBlueprint financial estimates
Financial estimateRevenue estimate
Valuation estimate
Blueprint leadership team
Management profileNumber of profiles
Blueprint funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Blueprint M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Blueprint
What does Blueprint do?
Firmographic data identifies Blueprint as a pharmaceutical research agency headquartered in Manchester, UK with 11-50 employees and founded in 2005. Documented business activity includes healthcare M&A advisory services through Blueprint Healthcare Real Estate Advisors, facilitating the sale of behavioral healthcare businesses and associated real estate in the US market, including transactions involving both operating businesses and real estate assets.
When was Blueprint founded?
Blueprint was founded in 2005. It employs 11 to 50 people.
Where is Blueprint based?
Blueprint is headquartered in Manchester, United Kingdom, in the Europe region.
Who are Blueprint's main competitors?
Broad incumbents on record are Kantar Health, IQVIA, ZS Associates and ICON plc. Inizio Advisory is listed as an emerging player. Direct peers are Research in Real Life (RiRL), The Research Partnership, Adelphi Group (Adelphi Research), SKIM and Cello Health.
Does Blueprint have an API?
No public API is recorded for Blueprint.
What industry is Blueprint in?
Blueprint's product category is Pharmaceutical Research Services. Its primary akta.pro industry code is HLAIAKAC, Value Dossier & Evidence Generation (AMCP/Global Value Dossier), with a secondary code of HLAGALAG, Medical Writing & Publications (Clinical/Safety/HEOR). Its NAICS code is 541.